Sheʾerit Yehudah : ...nes hatsalat Yiśraʾel ʻal yede Mordekhai ṿe-Ester /

Detached from Bikure ha-ʻitim, v. 8.

Sifre de-agadeta ʻal megilat Ester ... kevuzat midrashim shonim: midrash Aba Gorion ... midrash Panim aherim ...

Added t.-p. in German.

Perchlorate ester; preparation and polymerization

Mode of access: Internet.

Zur Kenntnis der Ester von Kohlenhydraten.

Thesis (doctoral)--Universitat Zurich.

Ueber die Einwirkung der Toluidine auf einige Ester der Dibrombernsteinsaure.

Thesis (doctoral)--Universitat Bern.

Ueber Dehydroschleimsaure : eine neue Darstellungmethode, sowie verschiedene Salze und Ester derselben.

Thesis (doctoral)--Georg-Augusts-Universitat, Gottingen.

Uber polychrome salze und ester aus oximidoketonen.

Thesis (doctoral)--

Ueber die elektrolytische Reduktion einiger aromatischer Nitrosauren und ihrer Ester /

Thesis (doctoral)--Grossherzogl. Badische Ruprecht-Karls-Universitat zu Heidelberg, 1894.

Über Salze und Ester des Benzhydroxamsäureäthylesters /

Thesis (doctoral)--Albertus-Universität zu Königsberg i. Pr., 1893.

Uber die Einwirkung von Acetamidin auf einige [omega]-Halogenketone und von Benzamidin auf [alpha]- Oxysauren und deren Ester /

Thesis (doctoral)--Universitat Rostock, 1905.

Platinum(II) olefin hydroarylation catalysts: tuning selectivity for the anti-Markovnikov product Tandem catalytic ester hydrogenation and deoxygenation of polyethylene terephthalate

Thesis (Master's)--University of Washington, 2016-06

Inhibitors of cholesteryl ester transfer protein - a step forward in the treatment of coronary artery disease?

Although the LDL cholesterol-lowering statins have reduced the mortality and morbidity associated with coronary artery disease (CAD), considerable mortality and morbidity remains. Increasing HDL cholesterol levels is associated with reduced CAD mortality and morbidity. In healthy subjects with mild dyslipidemia, treatment with JTT-705 decreased cholesteryl ester transfer protein (CETP) activity, increased HDL cholesterol and decreased LDL cholesterol. Similarly, another CETP inhibitor, torcetrapib, has recently been shown to increase HDL cholesterol by 46%, decrease LDL cholesterol by 8% and have no effect on triglycerides in subjects with HDL cholesterol levels below 1.0 mmol/l. Increasing HDL cholesterol with inhibitors of CETP represents a new approach to dyslipidemia that requires further investigation, especially in patients with CAD.